Altium Capital Management »

Argenx Se shares owned by Altium Capital Management

Quarter-by-quarter ownership of Argenx Se (ARGX) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Argenx Se

Tip: Access up to 7 years of quarterly data

All positions including Argenx Se held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Argenx Se by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.9M 23k 430.04

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Intra Cellular Therapies (ITCI)
Sarepta Therapeutics (SRPT)
Insmed Com Par $.01 (INSM)
Alimera Sciences Com New
Skye Bioscience Com New (SKYE)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Avadel Pharmaceuticals Com Shs (AVDL)
Catalyst Pharmaceutical Partners (CPRX)
Contineum Therapeutics Cl A (CTNM)
Rezolute Com New (RZLT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for Altium Capital Management

Top funds holding Argenx Se

T. Rowe Price Associates
Artisan Partners Limited Partnership
Henderson Group
T. Rowe Price Investment Management
BlackRock
Morgan Stanley
Citadel Advisors
Bellevue Group
ClearBridge Advisors
Paradigm Biocapital Advisors
Holocene Advisors
Deep Track Capital
Bank of America Corporation
Susquehanna International
Bamco

View all funds holding Argenx Se